What are the side effects of Tamiflu (oseltamivir)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Side Effects of Tamiflu (Oseltamivir)

Tamiflu (oseltamivir) commonly causes gastrointestinal side effects, particularly nausea and vomiting, which can be minimized by taking the medication with food. 1

Common Side Effects

Gastrointestinal Effects

  • Nausea: Occurs in approximately 10% of adults (compared to 6% with placebo) 2, 1
  • Vomiting: Occurs in approximately 9% of adults (compared to 3% with placebo) and 14% of children (compared to 8.5% with placebo) 2
  • Diarrhea: Reported in <5% of patients 2
  • Taking oseltamivir with food can reduce the severity of these gastrointestinal side effects 2, 1
  • Approximately 1% of patients discontinue the medication due to gastrointestinal side effects 2

Other Common Side Effects (each reported by <5% of patients)

  • Headache
  • Dizziness
  • Sinusitis
  • Nasal symptoms
  • Bronchitis
  • Cough
  • Ear, nose, and throat infections 2

Serious Side Effects

Neuropsychiatric Events

  • Transient neuropsychiatric events (self-injury or delirium) have been reported, particularly among adolescents and adults in Japan 2, 3
  • The FDA advises monitoring patients, especially children and adolescents, for abnormal behavior during treatment 2, 4
  • Several analyses have found that oseltamivir is not associated with an increased risk for neuropsychiatric events 2
  • Research suggests these effects may be related to increased dopamine levels in the brain 5

Allergic Reactions

  • Serious skin and allergic reactions can occur 4
  • Stop taking oseltamivir and seek medical help immediately if you experience:
    • Skin rash or hives
    • Blisters or peeling skin
    • Mouth sores
    • Itching
    • Facial swelling
    • Breathing difficulties
    • Chest pain or tightness 4

Special Populations

Respiratory Disease

  • Unlike zanamivir (another influenza antiviral), oseltamivir does not have specific warnings against use in patients with underlying respiratory disease 2

Pregnancy

  • Oseltamivir is a "Pregnancy Category C" medication
  • Should be used during pregnancy only if potential benefit justifies potential risk to the fetus
  • No adverse effects have been reported among women who received oseltamivir during pregnancy or among infants born to such women 2

Children

  • Limited safety data exists for children under 1 year of age
  • Careful attention to dosing is essential in young children 2, 1

Drug Interactions

  • Limited clinical data regarding drug interactions
  • Oseltamivir is excreted in the urine by glomerular filtration and tubular secretion via the anionic pathway
  • Potential for interaction with other drugs excreted by this pathway
  • Coadministration with probenecid results in reduced clearance of oseltamivir carboxylate by approximately 50% and a corresponding twofold increase in plasma levels 2

Practical Considerations

  • Side effects are generally mild and transient 6
  • In outbreak settings, mass prophylaxis with oseltamivir has shown higher rates of adverse effects and non-completion of therapy (up to 41% of recipients reporting side effects) 7
  • Taking oseltamivir with a light snack can reduce gastrointestinal side effects 6
  • Monitor children and adolescents closely for abnormal behavior during treatment 4

Remember that despite these potential side effects, oseltamivir remains an effective treatment for influenza when initiated promptly, reducing the duration of symptomatic illness and hastening return to normal activity levels 8.

References

Guideline

Oseltamivir Side Effects and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Adverse drug effects following oseltamivir mass treatment and prophylaxis in a school outbreak of 2009 pandemic influenza A(H1N1) in June 2009, Sheffield, United Kingdom.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.